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ABSTRACTS 
Purpose: Lymphadenopathy is defined as an abnormality in the size and/or character of lymph node. In this study  we 
aimed to describe the clinical and laboratory findings of benign and malignant causes of peripheral lymphadenopathy in 
childhood. 
Material and Methods: Two hundred and twenty four patients who were admitted to the clinic with peripheral LAP were 
evaluated. Age, gender, laboratory and radiologic findings, final diagnoses, and duration, localization, size, consistency, 
spread, and accompanying local and systemic symptoms of LAP were determined. Benign and malignant causes of 
peripheral lymphadenopathy were compared. 
Results: One hundred twenty-six patients (56.0%) were male and 98 patients (44.0%) were female. After the first 
evaluation the patients were divided into two groups. The first group included 186 patients with benign causes and the 
second group included 38 patients with malignant causes. One hundred and sixty four of 224 patients (73.2 %) had 
localized peripheral lymphadenopathy. The most frequent cause of localized lymphadenopathy in the benign group was 
acute lymphadenitis (34.8%). The most common cause of localized lymphadenopathy in the malignant group was 
Hodgkin’s lymphoma (4.3%). Sixty of 224 (26.8%) patients  had generalized peripheral lymphadenopathy. The most 
significant cause of generalized lymphadenopathy in the benign lymphadenopathy group was Epstein–Barr virus 
(10.0%), whereas Hodgkin’s lymphoma (23.3%) was the most common cause  in malign lymphadenopathy group. 
Localized and generalized lymph node enlargement was most frequently found in cervical region. The most frequent site 
of involvement among benign and malignant cases was the cervical area. The results revealed that findings such as 
chronic course, generalized LAP, supraclavicular, cervical and inguinal location, organomegaly, hilier LAP, abdominal 
LAP, and abnormal laboratory findings (thrombocytopenia and blasts on the peripheral blood smear) were associated 
with malignant diseases. 
Conclusion: Infections are the most common cause of peripheral LAP. The risk of malignany increases with the age of 
child and the duration of LAP.   Older children with chronic LAP,  generalized LAP associated with organomegaly, 
abnormal laboratory findings should be considered as malignant LAP. 
Key words: Child; lymphadenopathy,  
Abbreviation: LAP;  lymphadenopathy 
ÖZET 
Amaç: Lenfadenopati, lenf nodunun boyut ve/veya karakterindeki anormallik olarak tanımlanır. Bu çalışmada amacımız 
çocukluk çağında selim ve malign nedenlere bağlı periferik lenfadenopatilerin klinik ve laboratuvar bulgularını 
belirlemek. 
Araştırma Makalesi / Research Article  
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Materyal ve Metod: Çalışmaya periferik lenfadenopati nedeni ile hastanemize başvuran 224 hasta alındı. Hastaların; 
yaşı, cinsiyeti, laboratuvar ve radyolojik bulguları, tanıları, lenfadenopatinin; süresi, lokalizasyonu, boyutu, kıvamı, 
yayılımı, eşlik eden lokal ve sistemik semptomları kaydedildi. Malign ve selim hastalıklara bağlı lenfadenopatilerin klinik 
ve laboratuvar özellikleri karşılaştırıldı.  
Bulgular: İki yüz yirmi dört hastanın 126’sı (%56.0) erkek, 98’i (%44.0) kız idi. Hastalar 2 gruba ayrıldı. Birinci grupta 
selim nedenlere bağlı lenfadenopatisi olan 186 hasta, ikinci grupta ise malign  nedenlere bağlı lenfadenopatisi olan 38 
hasta mevcuttu. Yüz altmış hastada(%73.2) localize lenfadenopati vardı.  Selim hasta  grubunda lokalize 
lenfadenopatinin en sık nedeni akut lenfadenitler (%34.8) iken, malign hasta grubunda en sık nedenin Hodgkin lenfoma 
(%4.3) olduğu tespit edildi. İki yüz yirmi dört hastanın 60’ında (%26.8) jeneralize lenfadenopati vardı. Jeneralize 
lenfadenopatinin selim hasta grubunda başlıca nedeni Epstein–Barr virus enfeksiyonu (%10.0) iken, malign hasta 
grubunda Hodgkin lenfoma (%23.3) olduğu tespit edildi. Servikal bölge lokalize ve jeneralize lenfadenopatilerde en sık 
tutulan bölgedir. Malign ve selim nedenlere bağlı lenfadenopailer en sık servikal bölgede görüldü.  Elde ettiğimiz 
sonuçlara göre kronik seyirli, jeneralize lenfadenopati, supraklavikular, servikal ve inguinal yerleşimli lenfadenopati, 
organomegali, abdomanial lenfadenopati, hilier lenfadenopati ve anormal laboratuvar bulgularının (trombositopeni, 
periferik yaymada blast ) varlığında öncelikle malign nedenler düşünülmelidir.  
Sonuç: Enfeksiyonlar çocukluk çağında periferik lenfadenopatinin en sık nedenidir. Malignite riski yaş ve 
lenfadenopatinin süresi ile artmaktadır. İleri yaş, kronik lenfadenopati, jeneralize lenfadenopati,  eşlik eden 
organomegali, anormal laboratuvar bulguların varlığında öncelikle malignite düşünülmelidir. 
Anahtar kelimeler: Çocuk, lenfadenopati 
Kısaltma: LAP; lenfadenopati 
INTRODUCTION 
 Lymphadenopathy (LAP) is defined as an 
abnormality in the size and/or character of lymph 
node. Since a large variety of disorders may lead 
to peripheral LAP in childhood, determining the 
cause of peripheral LAP in children can be difficult. 
Lymphadenopathy  is a common finding in 
childhood which frequently causes problems for 
parents and physicians when patients underwent 
invasive and sometimes unnecessary procedures 
to establish a diagnosis. Until recently there was 
no consensus on the size of a lymph node which 
would be classified as large. Although there is 
some variation depending on the anatomic area, 
lymph nodes > 1 cm in size are commonly 
accepted as enlarged
1,2
.
 
In this study we aimed to 
evaluate peripheral LAP regarding etiology and 
clinical findings; to define the characteristics of 
benign and malignant lymph node enlargement by 
analyzing patient history, physical examination and 
laboratory findings, and to determine the 
differences between these two types. 
 
 
METHODS and PARTICIPANTS  
 This prospective study involved 224 patients 
with peripheral LAP who were admitted to Dr. Sami 
Ulus Pediatrics Training and Research Hospital 
over a 2-year period. The sample included 98 
female and 126 male patients between 2 months 
and 16 years of age. One hundred eighty-six 
patients were in the benign LAP group and 38 
patients were in the malignant LAP group. The 
abnormal LAP was classified depending on the 
duration, extension and size. The maximum 
diameter of the LAP to be considered abnormal 
was 10 mm, with the exceptions of 1-2 mm at the 
supraclavicular region, 5 mm at the epitrochlear, 
post-auricular and occipital regions and 15 mm at 
the inguinal region. We caterogorized the lymph 
nodes accordng to the size as <2, 2-4, and >4 cm.  
The enlargement of lymph nodes in one 
contiguous anatomic region was classified as 
localized LAP, and the involment of two or more 
noncontiguous lymph node region was classified 
as generalized LAP. The patients with LAP for < 2  
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weeks were categorized as acute LAP, and the 
patients with LAP  for > 2 weeks were categorized 
as chronic LAP. We recorded axillary body 
temperature at presentation or measured by 
parents at home. Axillary body temperature over 
38 º has to be considered as fever. Children 
suffering from neck mass caused by congenital 
abnormalities were not included in the study.  
Histories of upper respiratory infections ,ear pain, 
and dental problems, weight loss, night sweats, 
fatigue, bleeding, cough, rash, arthralgias, contact 
with animals, vaccination history, co-existing 
systemic illnesses, previous antibiotic use, and 
family history of tuberculosis were interrogated. 
The first assessment of the patient was directed 
towards predicting the etiology for LAP considering 
the history and findings on physical examination. 
The complete blood cell count, peripheral smear, 
erythrocyte sedimentation rate (ESR), and C-
reaktif protein (CRP) were recorded.  A throat 
culture, chest radiograph, purified protein 
derivative (PPD), and viral serology of patients with 
acute LAP were obtained. Fluctuant nodes were 
aspirated for culture. For patients with possible 
tuberculous LAP, family screening, acid resistant 
bacteria (ARB), BACTEC, Polymerase chain 
reaction (PCR) and culture analyses for 
Mycobacterium tuberculosis in sputum or fasting 
gastric juice were performed and the diagnosis 
was confirmed with biopsy. Thoracic CT is also 
performed. For patients with generalized  LAP  in 
addition to these analyses, Epstein Barr Virus 
(EBV), Cytomegalovirus (CMV), human 
immunodeficiency virus (HIV),  Herpes simplex 
virus  (HSV), measles, rubella, salmonella, and 
brucella serology were also determined. The 
patients with organomegaly were examined 
utilizing abdominal ultrasonography (USG). 
Excisional lymph node biopsy was conducted for 
patients who had not responded to 4-8 weeks of 
antibiotic treatment. Informed consent was 
obtained from the parents of all children. 
 
 
Statistical Methods 
 Statistical analyses were performed utilizing 
SPSS 15.0 for Windows (SPSS, Inc., Chicago, IL, 
USA). Data was defined by descriptive statistics (n, 
%). Demographic data was shown by mean and 
standart deviation. A chi square test was 
conducted to compare the gender variable 
between the two groups, and Student’s t-test was 
used to compare the age variable. A chi square 
test was also conducted to compare the symptoms 
and laboratory findings of the two groups. The 
levels of significance are indicated by p values 
<0.05. 
 
Findings 
 One hundred twenty-six of 224 patients 
(56.0%) were male and 98 (44.0%) were female, 
with a female-to-male ratio of 0.77. The youngest 
patient was 2 months old and the oldest patient 
was 16 years old. One hundred eighty-six of the 
LAP patients (83.0%) had benign and 38 (17.0%) 
had malignant causes. The benign LAP group 
consisted of 186 patients (84 females and 102 
males) between 2 months and 16 years of age; the 
mean age was 63.5 ± 43.5 months. The malignant 
LAP group included 38 patients (12 females and 
26 males) between 8 months and 15 years of age; 
the mean age was 94.0 ± 47.3 months. While there 
was no statistically significant difference with 
respect to gender between the groups (p=0.35), 
the mean age for the two groups differed 
statistically (p=0.01). The etiologic distribution of 
the benign and malignant LAP groups with respect 
to age is shown in Tables 1 and 2, respectively.  
 The etiologic and local distributions of 
peripheral LAP to the localization is showed in 
Table 3. While the most frequent cause of 
localized LAP in the benign LAP group was acute 
lymphadenitis (34.8%), the most common cause 
was Hodgkin’s lymphoma (4.3%) in the malignant 
LAP group. One hundred and sixty four of 224 
patients (73.2 %) had localized, sixty of 224 
(26.8%) patients  had generalized peripheral. LAP 
(Table 3). The most significant cause of 
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generalized LAP in the benign LAP group was 
EBV (10%), whereas Hodgkin’s lymphoma (23.3%) 
was the most common  cause in malignant LAP  
group. (Table 3). 
Table 4 summarizes comparison of  the detailed 
symptoms and clinical findings of the benign and 
malignant LAP  groups. One hundred and sixty 
four of 224 patients (73.2 %) had acute LAP ,  sixty 
of 224 (26.8%) patients  had chronic generalized. 
LAP (Table 4). One hundred fifty six  of 164 
(95.0%)  patients in the acute LAP group had 
benign etiologies and 8 (5.0 %)   had malign 
etiologies. Thirty eight of 60  (63.3%)  patients in 
the generalied LAP had benign etiologies whereas 
22 (36.7 %) had malign etiologies. Twelve patients 
in the benign LAP group with chronic LAP were 
diagnosed with tuberculosis; 83.0% of these 
patients were PPD-positive. There was no 
significant difference between the extensions of 
the LAP, consistency of LAP and fluctuation of 
LAP in the benign and malignant LAP  groups 
(P>0.05, Table 4). We found  the duration of LAP 
was longer in malignant LAP group than benign 
LAP group (P<0.001, Table 4). When the 
distribution of LAP compared, we found localized 
LAP was most frequent in the benign LAP group 
(P<0.001, Table 4). We found that cervical, 
submandibular and inguinal regions were the most 
common localization of LAP both in malignant and 
benign LAP groups. We determined 
supraclavicular LAP in 12 patients; malignancy 
was detected in 11 patients. We also found that 
fever is more common in the benign LAP group 
whereas hepatosplenomegali is more common in 
the malign LAP group (P<0.001, Table 4).  
 Table 5  lists the comparison of the laboratory 
and radiologic findings of the two study groups. 
There were no significant difference between the  
CRP and sedimentation levels in the benign and 
malignant LAP  groups (P>0.05, Table 4). We 
found hilier LAP, hepatosplenomegali and 
mesenteric LAP , thrombocytopenia, blasts on the 
peripheral blood smear were significantly higher in 
the malign LAP group (P<0.001, Table 5). 
 Table 6 summarizes the etiologic distribution 
of the 50 patients who underwent excisional lymph 
node biopsy in order to evaluate etiology of 
peripheral LAP. 
Table 1. Benign lymhadenopathy etiology according to the age groups 
 
Disease 
Age 
0-23 MONTHS 2-5 YEARS 6-10 YEARS 11-16 YEARS 
n % n % n % n % 
Acute lymphadenitis 24 63.2 23 33.9 10 16.4 4 21.1 
Upper respiratory infection 9 23.7 14 20.6 14 23.0 4 21.1 
EBV infection - - 7 10.3 8 13.1 1 5.3 
Tuberculosis lymphadenitis - - 2 2.9 6 9.8 4 21.1 
Acute otitis media 4 10.5 5 7.4 2 3.3 - - 
Sinusitis - - - - 8 13.1 - - 
Dental infection - - 1 1.5 4 6.6 1 5.3 
Rubella - - 2 2.9 3 4.9 - - 
Pyoderma - - 2 2.9 1 1.6 - - 
Conjunctivitis - - 3 4.4 - - - - 
Brucellosis - - 1 1.5 - - 2 10.3 
Toxoplasmosis - - - - 3 4.9 - - 
CMV 1 2.6 2 2.9 - - - - 
Kawasaki syndrome - - 3 4.4 - - - - 
Other - - 3 4.4 2 3.3 3 15.8 
Total 38 100.0 68 100.0 61 100.0 19 100.0 
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Table 2. Malign lymphadenopathy etiology according to the age groups 
Disease Age 
0-23 MONTHS 2-5 YEARS 6-10 YEARS 11-16 YEARS 
n % n % n % n % 
Hodgkin’s lymphoma - - 4 40.0 10 58.8 7 70.0 
*ALL 1 100.0 2 20.0 2 11.7 3 30.0 
**AML - - 2 20.0 1 5.9 - - 
Burkitt lymphoma - - - - 1 5.9 - - 
Dentritic cell lymphoma - - - - 1 5.9 - - 
Neuroblastoma - - 1 10.0 - - - - 
Yolk sac tumor - - - - 1 5.9 - - 
T cell lymphoma - - 1 10.0 1 5.9 - - 
Total 1 100.0 10 100.0 17 100.0 10 100.0 
*ALL: acute lymphoblastic leukemia            **AML: acute myelocytic leukemia   
Table.3. Causes of malign and benign lymphadenopathy (LAP) to the localization 
Etiology of benign LAP Localized LAP General LAP 
 n % n % 
Acute lymphadenitis 57 34.8 4 6.7 
Upper respiratory infection 36 22.0 5 8.3 
EBV 10 6.0 6 10.0 
*Tbc, lymphadenitis 10 6.0 2 3.3 
Acute otitis media 10 6.0 1 1.7 
Sinusitis 6 3.7 2 3.3 
Dental infection 5 3.1 1 1.7 
Pyoderma 3 1.8 0 0.0 
Conjunctivitis 3 1.8 0 0.0 
CMV 2 1.2 1 1.7 
Kawasaki syndrome 2 1.2 1 1.7 
Rubella 1 0.8 4 6.7 
Brucellosis 0 0.0 3 5.0 
Toxoplasmosis 0 0.0 3 5.0 
Other 3 1.8 5 8.3 
Total 148 90.2 38 63.4 
   
Etiology of malign  LAP   
Hodgkin’s lymphoma 7 4.3 14 23.3 
ALL 4 2.5 4 6.6 
AML 1 0.6 2 3.3 
Burkitt lymphoma 1 0.6 0 0.0 
T cell lymphoma 1 0.6 1 1.7 
Yolk sac tumor 1 0.6 0 0.0 
Neuroblastoma 1 0.6 0 0.0 
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Dentritic cell lymphoma 0 0.0 1 1.7 
Total 16 9.8 22 36.6 
     
Overall TOTAL 164 100.0 60 100.0 
*Tbc: Tuberculosis,  
Table.4. Symptoms and clinical findings of patients with benign and malign lymphadenopathy  
FINDINGS BENIGN MALIGN  
 n % n % p 
General symptoms       
Fever 119 78.3 25 30.9  0.01 
Night sweats 13 8.6 15 18.5  
Weight loss 11 7.2 20 24.7  
Fatique 9 5.9 21 25.9  
Distribution      
Local 148 79.6 16 42.1  0.001 
General 38 20.4 22 57.9  
LAP duration      
Acute 156 83.9 8 21.0   0.001 
Chronic 30 16.1 30 79.0    
Localization      
Cervical  125 47.3 35 42.7    0.87 
Submandibular 67 25.4 10 12.2  
Inguinal 28 10.6 15 18.3  
Axillary 26 9.8 9 11.0  
Post auricular 11 4.2 2 2.4  
Pre-auricular 5 1.9 0 0.0  
Suboccipital 1 0.4 0 0.0  
Supraclavicular 1 0.4 11 13.4  
Size of  LAP      
<2 cm 73 39.2 16 42.1 0.86 
2-4 cm 55 29.6 12 31.6  
>4 cm 58 31.2 10 26.3  
Mobility of LAP      
Mobile 103 55.4 18 47.4    0.76 
Fixed 83 44.6 20 52.6    
Fluctuation of LAP      
Yes 18 9.6 0 0.0    0.66 
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No 168 90.4 38 100.0  
Temperature elevation and sensitivity      
Yes 75 40.4 1 2.7   0.001 
No 111 59.6 37 97.3  
Hepatomegaly      
Yes 24 12.9 17 44.7 0.001 
No 162 87.1 21 55.3  
Splenomegaly      
Yes 12 6.5 20 52.6   0.001 
No 174 93.5 18 47.4  
Table.5. Laboratory and radiologic findings of patients with benign and malign lymphadenopathy  
LABORATORY AND 
RADIOLOGIC FINDINGS 
BENIGN MALIGN  
 n % n % p 
 
Anemia 
 
84 
 
92.3 
 
27 
 
64.3 
 
0.001 
Thrombocytopenia 7 7.7 15 35.7  
White blood cell count       
Leukocytosis 59 88.1 10 45.5 0.001 
Leukopenia 8 11.9 12 54.5  
Peripheral blood smear      
Shift to the left 116 87.2 13 44.8     0.001 
Atypical lymphocytes 17 12.8 4 13.8  
Blasts - 0.0 12 41.4  
Sedimentation      
High(>20mm/h) 127 68.3 31 81.6 0.08 
Normal(<20mm/h) 59 31.7 7 18.4  
CRP      
High(>6 mg/dl) 131 70.4 22 57.9 0.09 
Normal(<6 mg/dl) 55 29.6 16 42.1  
P-A chest radiography      
Abnormal(hilier LAP) 21 11.3 10 26.3  0.04 
Normal 165 88.7 28 73.7  
Abdominal USG      
Hepatomegaly 24 54.5 25 39.7  0.01 
Splenomegaly 18 41.0 24 38.1  
Lymphadenopathy 2 4.5 14 22.2  
 CRP: C-reactive protein,            P-A: postero-anterior,         USG: ultrasonography 
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Table. 6.. Distribution of cases with lymph node biopsies 
Neoplastic diseases n % 
*HH 21 42.0 
**NHL - - 
 T cell lymphoma 2 4.0 
 Burkitt lymphoma 1 2.0 
Dentritic cell lymphoma 1 2.0 
Neuroblastoma 1 2.0 
Yolk sac tumor 1 2.0 
   
Granulomatous diseases   
Tuberculosis 9 18.0 
Toxoplasmosis 1 2.0 
   
Reactive lymph node hyperplasia 8 16.0 
   
Others   
Mucormycosis lymphadenitis 1 2.0 
Castleman disease 1 2.0 
Measles 1 2.0 
Chronic lymphadenitis 2 4.0 
Total 50 100.0 
*HH: Hodgkin’s disease                   **NHL: non- Hodgkin’s Lymphoma 
DISCUSSION 
 Peripheral LAP in children might be an 
alarming sign of serious disease such as 
malignancy, systemic disease, infections, 
autoimmune disorders, miscellaneous and 
iatrogenic. Lymphadenopathy is a common finding 
in children. Since it can be manifestation of a 
serious systemic disease or malignancy, 
determining the cause of peripheral LAP in 
children can be difficult. The presence of lymph 
nodes can be diagnosed during an ordinary 
physical examination in 38.0%-45.0% of healthy 
children3.  In infants < 6 months of age, palpable 
LAP was present in 38.0% and the most frequent 
sites were the occipital and post-auricular areas. 
Of healthy children between 3 and 5 years, 63.0%  
 
 
and 24.0% had LAP in the cervical and 
submandibular areas, respectively1,2.  
 Lymphadenopathy is a common finding in 
children and in the majority of cases lymph node 
enlargement occurs response to the benign and 
self limited disease. Local or systemic infections 
are common causes of peripheral LAP in children. 
Previous studies reported that 70.0%-87.0% of 
patients with peripheral LAP  have benign 
causes3-7. Similar to other studies we found that 
83.0% of patients with peripheral LAP have benign 
causes. Acute lymphadenitis (32.7%) and upper 
respiratory infections (22.0%) were the most 
common causes of benign LAP  in our study.  
 Acute lymphadenitis is defined as enlarged, 
inflamed, and tender of  lymph nodes. It is often a  
Özkale et al.       Cukurova Medical Journal 
 
 426 
complication of bacterial infections, although it can 
also be caused by viruses or other disease agents. 
Staphylococcus and streptococci are the most 
common infectious agents in children especially 
under 4 years of age. Acute unilateral cervical 
lymphadenitis is usually caused by staphyloccocus 
aureus or streptococcus pyogenes in over 80% of 
cases. A group beta hemolytic streptococci 
(AGBS) and anaerobic bacteria are another 
common cause of acute cervical lymphadenitis and 
generally occurs in children older than 3 years of 
age. Acute pyogenic lymphadenitis is mostly 
localized to the submandibular (50%-60%) and 
anterior cervical (25%-30%)  region in children  
between 1 and 4 years of age
2,8
. In the current 
study, patients had acute lymphadenitis, which 
47.3% had cervical and 25.4%  had submandibular 
lymph node involvement. Fluctuation existed in 
9.6% of the patients; Staphylococcus aureus and 
AGBS were isolated in 55.5% and 5.5% of the 
lymph nodes with fluctuation, respectively. 
 Age is an important factor in differentiating 
between benign and malignant LAP in childeren. 
The rate of malignant etiologies of peripheral LAP 
is low in children, but increases with age
8-10
. 
Soldes et al reported the risk of malignancy in 
peripheral LAP increases with the age of child, size 
of LAP and the number of involved sites
11
. On the 
other hand,  in 1980 Lee et al  reviewed 628 
patients undergoing nodal biopsy and found  that 
age is the most important factor in estimating the 
probability of whether the LAP is due to a benign 
or malignant process
12
. We also found the mean 
age of  the patients  in the malignant LAP  group 
were older than benign LAP group. We have 
determined  malign LAP only in 1 patient between 
0-23 months old whereas 38 patient had benign 
LAP between the same age group.  
 Another important consideration in the 
evaluation of patients with peripheral  LAP is the 
presence of systemic symptoms. “B” symptoms, 
such as fever, weight loss, and night sweats, 
accompany lymphoproliferative diseases along 
with infectious illnesses. Knight  et al reported that  
fever of unknown origin and weight loss persisting 
for > 1 week are associated with malign LAP. On 
the other hand  Soldes et al  reported that fever 
does not have a clinical significance in the 
diagnosis of patients with LAP
4,11
.
 
 Weight loss, 
fatigue, and arthralgias are the most common 
symptoms which are  associated with malignancy 
and collagen tissue diseases
13,14
. Kumral et al 
reported that weight loss was more frequently 
associated symptom in the malignant LAP group 
whereas fever was more frequent in patients with 
benign LAP  (5). We also found that fever is more 
common in the benign LAP group. 
 Based on our data, most of the  patients  had 
localized LAP (73%). We determined  the most 
frequent cause of localized LAP in the benign LAP 
group was acute lymphadenitis (34.8%) and the 
most common cause of localized LAP in the 
malignant LAP group was Hodgkin’s lymphoma 
(4.3%). İnfections, autoimmune diseases, and 
malignancy are the most common cause of 
generalized LAP in children. Numerous pathogens 
have been associated with generalized LAP 
including EBV, CMV, adenovirus , rubella and 
toxoplasmosis
11-14
. We found sixty of 224 (26.8%) 
patients  had generalized peripheral LAP. We 
determined  the most common cause of 
generalized LAP in the benign LAP group was 
Epstein–Barr virus infections (10.0%) and the most 
common cause  was Hodgkin’s lymphoma (23.3%) 
in malign LAP group. The risk of malignant disease 
was higher in patients who had generalized LAP
7
. 
We also  found that generalized LAP  was more 
common in the malignant LAP group and localized 
LAP  was more common in the benign LAP  group 
similiar to previous studies
5,6
.  
 Although the duration of LAP is important in 
the differential diagnosis of peripheral LAP, it is not 
a specific finding. Infections should be considered 
first in the etiology of cases with peripheral LAP < 
2 weeks in duration, and malignancy and 
granulomatous diseases are suggestive of chronic 
LAP patients
5,6,9,15
. In the current study, the 
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duration of LAP was longer in malignant LAP 
group than benign LAP group.  
 The localization of LAP is important in terms 
of etiologic factors. Cervical LAP is the most 
common localization for both benign and malignant 
diseases
5,6,9,14
. The incidence of malignancy is 
higher in supraclavicular, infra-cervical, and 
posterior cervical LAP
5-7,9
. Our study also showed 
that supraclavicular, cervical, and inguinal LAP 
were significant in the presence of malignant LAP. 
So as suggested in the literaure, children with 
supraclavicular or  cervical LAP should be selected 
for early lymph node biopsy. On the other hand we 
found an increased incidence of submandibular 
LAP in the benign LAP group. We assume that this 
may result from the high frequency of 
lymphadenitis cases among the patients with 
benign diseases.  
 There have been a variety of findings with 
respect to the importance of lymph node size in the 
differential diagnosis of LAP. LAP > 2 cm in size 
are suspicious for malignancies or granulomatous 
diseases and LAP < 1 cm in size suggest benign 
diseases
5,7,9
. Karaman et al reported that there is 
no significant difference between benign and 
malignant diseases with respect to LAP size similar 
to our findings
10
. On the other hand Kumral et al  
reported that LAP larger than 3 cm represent a 
greater risks for malignancies
5
.    
 Malignant and granulomatous diseases 
should be considered in patients with hard or 
mixed LAP, fixed  to the surrounding tissue. 
Although some studies maintain that fixed lymph 
nodes are an indicator of increased risk for 
malignant and granulomatous diseases, other 
studies claim that the mobility of  lymph nodes is 
not a significant finding with respect to the 
differential diagnosis
5,6,11,14,16
. In the current study, 
fixed LAP was identified in 44.6 % of the benign 
group and 52.6% of malignant cases. The higher 
incidence of fixed LAP in the benign group is 
thought to be the result of the higher number of A. 
lymphadenitis and M. tuberculosis cases.   
 The presence of organomegaly and 
peripheral lymphadenopathy in children is a strong 
indicator of the seriousness of a disease. Knight et 
al reported that there is a serious triggering effect 
in 56.0% and 40.0% of hepatomegaly and 
splenomegaly cases, respectively
4
. In our study, 
organomegaly was significantly more frequent 
among the malignant patient group. There are 
other studies which have been conducted in 
Turkey with similar results
5,7
.    
 Lymphadenopathy  may be an important 
indicator of a malignant disorder
1,2
. Therefore, it is 
very important to establish a early diagnosis, to 
start treatment, and to achieve a good prognosis.  
Hemoglobin, platelet and white blood cell counts 
are useful findings in the differential diagnosis of 
LAP patients. Leucocytosis is apparent in 
infectious LAP, whereas thrombocytopenia, 
leucocytosis, or leucopenia are apparent in the 
course of malignancies
5,7,17,18
. Fijten et al   claimed 
that the white blood cell count is of no clinical 
significance in patients with malignant diseases
13
. 
In the current study, the incidences of anemia, 
thrombocytopenia and leucopenia were significant 
in the malignant  LAP group, but the white blood 
cell counts were not a diagnostic criterion. The 
peripheral smear constitutes the first step in the 
evaluation of patients with LAP
10
. An elevated ESR 
and CRP, also known as acute phase reactants, 
did not reveal any clinical significance in the 
differential diagnosis of patients with malignant 
LAP
5,7
. 
 Many infectious and malignant diseases can 
accompany abdominal LAP
2,18
. The incidence of 
abdominal LAP is more frequent in patients with 
malignant diseases than benign diseases
5,9,10
. 
Similarly, it was identified in our results that 
abdominal LAP was present in 4.5 % of patients 
with benign diseases and in 22.2 % of patients with 
malign diseases.  
 In the current study, excisional lymph node 
biopsies were performed on 50 patients (22.3%). 
Most of the patients had been histopathologically 
diagnosed malignancies(54.0%). Histopathologic  
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examination showed  granulomatous diseases in 
10 patients (20%)  and it was consistent with 
reactive lymphoid hyperplasia in 8 patients (16%). 
The malignancy rates in patients with persistent 
LAP were 30.0%, 27.0%, and 38.0% in studies 
conducted by Kumral et al , Karadeniz et al   and 
Karaman et al respectively
5,9,10
.  Excisional biopsy 
should be considered with LAP hard or matted, 
fixed to the surrounding tissue, increasing rapidly 
in size, unresponsive to antibiotic therapy over 4-8 
weeks, localized cervical or supraclavicular region, 
presence of organomegali and mediastinel LAP, 
associated symptoms like fever of unknown origin, 
night sweeats, weight loss or difficulty in 
diagnosis
2-5,8,20
. 
CONCLUSION 
 Overall, 83.0% of LAP cases in childhood are 
caused by benign diseases. The most frequent site 
of involvement both benign and malignant cases 
was the cervical region. When supraclavicular LAP 
is present, malignancy and early lymph node 
biopsy should be considered in all age groups. 
Malignant disease should be considered in 
children who are older, have a chronic course, 
generalized LAP, presence of organomegaly, hilier 
LAP, abdominal LAP and abnormal laboratory 
findings (thrombocytopenia and blasts on the 
peripheral blood smear).  
 Language, grammar, and spelling errors have 
been corrected.  
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